scispace - formally typeset
J

Jerrold M. Olefsky

Researcher at University of California, San Diego

Publications -  606
Citations -  83310

Jerrold M. Olefsky is an academic researcher from University of California, San Diego. The author has contributed to research in topics: Insulin & Insulin resistance. The author has an hindex of 143, co-authored 595 publications receiving 77356 citations. Previous affiliations of Jerrold M. Olefsky include University of Colorado Boulder & University of Michigan.

Papers
More filters
Journal ArticleDOI

Protein Phosphatase 2A Forms a Molecular Complex with Shc and Regulates Shc Tyrosine Phosphorylation and Downstream Mitogenic Signaling

TL;DR: It is concluded that PP2A negatively regulates the Ras/MAP kinase pathway by binding to Shc, inhibiting tyrosine phosphorylation and that this defines a new mechanism of small-t-antigen action to promote mitogenesis.
Journal ArticleDOI

Induction of hypertriglyceridemia by a low-fat diet.

TL;DR: The data indicate that the moderate increase in dietary CHO associated with a low fat diet will elevate plasma triglyceride levels, and it is believed that more caution is necessary before recommending the wide-spread use of low fat diets for heart disease prevention.
Journal ArticleDOI

Cellular Insulin Resistance in Adipocytes from Obese Polycystic Ovary Syndrome Subjects Involves Adenosine Modulation of Insulin Sensitivity

TL;DR: In this article, a postbinding defect in insulin signal transduction was found in polycystic ovary syndrome (PCOS) and N6-phenylisopropyl adenosine treatment was shown to normalize insulin sensitivity in obese normal cycling (NC) and PCOS subjects.
Journal ArticleDOI

Direct and Indirect Effects of Insulin to Inhibit Hepatic Glucose Output in Obese Subjects

TL;DR: In a group of insulin-resistant obese subjects, glucose-clamp studies were performed at peripheral insulin levels of 35 ± 3 μU/ml; glucose disposal did not increase, whereas HGO was suppressed by 82%, suggesting that insulin can suppress HGO through indirect extrahepatic actions.
Journal ArticleDOI

MiR-690, an exosomal-derived miRNA from M2-polarized macrophages, improves insulin sensitivity in obese mice.

TL;DR: This paper showed that miR-690 is highly expressed in M2 BMDM exosomes and functions as an insulin sensitizer both in vivo and in vitro, which could be a new therapeutic insulin-sensitizing agent for metabolic disease.